Thoughts on COVID-19 and autoimmune diseases
- PMID: 32341791
- PMCID: PMC7174058
- DOI: 10.1136/lupus-2020-000396
Thoughts on COVID-19 and autoimmune diseases
Abstract
Over the 2 months since coronavirus first appeared in China, cases have emerged on every continent, and it is clear that patients with autoimmune diseases might also be affected. Coronavirus disease 2019 (COVID-19) is a highly contagious viral illness with a mortality rate approaching 2%. Here we discuss the challenges that patients with autoimmune diseases might face and the information on using immunomodulatory therapies like chloroquine, tocilizumab and baricitinib to quench the cytokine storm in patients with very severe COVID-19 pneumonia.
Keywords: autoimmune diseases; cytokines; inflammation.
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
References
-
- World Health Organization Coronavirus disease 2019 (COVID-19) situation report 48, 2020. Available: https://www.who.int/docs/default-source/coronaviruse/situation-reports/2...
-
- Centers for Disease Control and Prevention Coronavirus disease 2019 (COVID-19) in the U.S, 2020. Available: https://www.cdc.gov/coronavirus/2019-ncov/cases-in-us.html#investigation
-
- National Institute of Allergy and Infectious Diseases Coronaviruses, 2020. Available: https://www.niaid.nih.gov/diseases-conditions/coronaviruses
-
- Centers for Disease Control and Prevention Interim clinical guidance for management of patients with confirmed coronavirus disease (COVID-19), 2020. Available: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-manageme...
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical